# Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients

> **NCT07116811** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 364 (estimated)

## Conditions studied

- Vestibular Schwannoma
- Facial Nerve Paralysis

## Interventions

- **DRUG:** Steroids therapy
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07116811
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 364 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07116811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07116811, "Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT07116811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*